DNL151. LRRK2: Denali therapeutics... - Cure Parkinson's

Cure Parkinson's

26,570 members27,876 posts

DNL151. LRRK2

Parsa profile image
6 Replies

Denali therapeutics announces decision to advance DNL151 into late stage clinical studies in Parkinson’s patients

Do you guys have any info re this? Anyone engaged in trial?

Written by
Parsa profile image
Parsa
To view profiles and participate in discussions please or .
6 Replies
jeffreyn profile image
jeffreyn

There was a PNT article about DNL151 about a month ago:

parkinsonsnewstoday.com/201...

jeffreyn profile image
jeffreyn in reply tojeffreyn

... and a Denali/Biogen DNL151 article about two months ago:

parkinsonsnewstoday.com/202...

Parsa profile image
Parsa in reply tojeffreyn

Thanks for sharing. I wanted to see if anyone is part of this. Do you know anyone?

jeffreyn profile image
jeffreyn in reply toParsa

No. Not yet.

Sapeye2020 profile image
Sapeye2020

Did you read this announcement?

Denali, Biogen Partner to Move DNL151 Into Late-stage Parkinson’s Trials

August, 10, 2020

LRRK2PD profile image
LRRK2PD

I considered trying to get involved but got scared by the two required spinal punctures. Also, they said that even if I were lucky enough to get the real drug (versus the placebo) and even if I had a very good response, I would have to stop when the study ended and would lose the benefit. Is that how all clinical trials work?

Not what you're looking for?

You may also like...

B12 Adenosylcobalamin form inhibits LRRK2

https://neurosciencenews.com/b12-lrrk2-parkinsons-disease-10996/...

Positive for the LRRK2 gene

I am positive for the LRRK2 gene. My father has pd and so did his Dad, as well as my mother’s Mom....
Missy0202 profile image

Symptoms with LRRK2 and GBA mutations

I would appreciate any feedback from anybody who had Fox Foundation genetic screening and happened...
felixned profile image

Parkinson's related to a gene called LRRK2

Article that appeared in the BUSINESS SECTION of the LOS ANGELES TIMES....
enjoysalud profile image

Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered

New clinical trial registered: Biogen and Denaliti have initiated the 2nd late-stage study of...